CompletedNot Applicable

Toxoplasmic Encephalitis in Patients With AIDS. Treatment and Prevention of Relapse

United States

Plain-language summary

To compare pyrimethamine and intravenous (IV) clindamycin vs. pyrimethamine and sulfonamides in the treatment of AIDS patients with central nervous system (CNS) Toxoplasma gondii.

Who can participate

Age range18 Years

SexALL

See this in plain English?

AI-rewrites the medical criteria so a patient or caregiver can understand them. Always confirm with the trial site.

Exclusion Criteria Co-existing Condition: Patients with the following conditions are excluded: * Opportunistic infection (Pneumocystis carinii pneumonia (PCP), cryptococcal meningitis) or other conditions (brain abscess) which would make treatment results difficult to interpret due to concurrent infection, disease, or therapy. Patients with other opportunistic infections or brain diseases are excluded. Patients with AIDS and cerebral toxoplasmosis.

Trial details

NCT IDNCT00002064

SponsorPalo Alto Medical Foundation

Sponsor typeOTHER

Study typeINTERVENTIONAL

View on ClinicalTrials.gov More Toxoplasmosis, Cerebral trials